Flublok Trivalent Northern Hemisphere
Product Images NDC 49281-725

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Flublok Trivalent Northern Hemisphere (NDC 49281-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Pasteur Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Label for FLUBLOK Trivalent Influenza Vaccine 2023-2024 Formula, 0.5 mL single-dose for intramuscular use. It is preservative-free and manufactured by Protein Sciences Corp. The label includes NDC 49281-620-88, lot number, and expiration date placeholders.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

FLUBLOK TRIVALENT NORTHERN HEMISPHERE Influenza Vaccine 45 mcg/0.5 mL prefilled syringes packaging label. Box contains 10 single-dose prefilled syringes for intramuscular use in adults 18 years and older. Label notes 2023-2024 formula and includes storage and formulation instructions. Distributed by Sanofi Pasteur Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.